Home / News / FAQ
FAQ

FAQ: Increased Healthcare Use Decades Before MS Diagnosis

FaqStaq News - Just the FAQs • July 18, 2025
By FAQstaq Staff
Read Original Article →
FAQ: Increased Healthcare Use Decades Before MS Diagnosis

Summary

A study reveals that individuals later diagnosed with multiple sclerosis (MS) have higher healthcare utilization rates, including more doctor visits, hospital admissions, and emergency room visits, decades before diagnosis, suggesting early warning signs that could lead to earlier diagnosis and treatment.

What does the study say about healthcare use before MS diagnosis?

The study found that individuals who are later diagnosed with MS tend to visit their doctors more, are admitted to hospitals more, and visit emergency rooms more frequently decades before their diagnosis, compared to those who don’t develop MS.

How long before MS diagnosis do these increased healthcare visits occur?

These increased healthcare visits often happen more than 20 years before an MS diagnosis is made.

Why is early diagnosis of MS important?

Early diagnosis allows patients to benefit sooner from medications being developed to address MS, potentially improving outcomes.

What are the implications of this study for MS diagnosis?

The study suggests that a high frequency of needing medical attention for certain health problems earlier in life could serve as early warning signs for MS, enabling earlier diagnosis and treatment.

Who is involved in developing medications for MS?

Companies like Clene Inc. (NASDAQ: CLNN) are involved in developing medications to address MS, as mentioned in the content.

Where can I find more information about Clene Inc.?

The latest news and updates relating to Clene Inc. (NASDAQ: CLNN) are available in the company’s newsroom at https://ibn.fm/CLNN.

What is BioMedWire?

BioMedWire is a specialized communications platform focusing on the latest developments in the Biotechnology, Biomedical Sciences, and Life Sciences sectors, part of the Dynamic Brand Portfolio @ IBN.

How can I receive alerts from BioMedWire?

To receive SMS alerts from BioMedWire, text ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only).

Where can I read more about this study?

You can read more about the study at BioMedWire.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 108978